LCB84, Anti-PD-1 monoclonal antibody — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-01 (month) in 3mo
ESTIMATED |
READOUT
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti
Phase 1/2 · Advanced Solid Tumors |
LigaChem Biosciences, Inc. | LCB84, Anti-PD-1 monoclonal antibody |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|